UBS AM’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.08K Buy
+108
New +$3.48K ﹤0.01% 3983

Other funds holding AVLN

UBS AM's AVLN Position: Q3 2026 in Review

UBS AM opened a new position in Avalyn Pharma (AVLN) in Q3 2026: 108 shares worth $3.08K. The stake represents ﹤0.01% of the portfolio and ranks #3983 among its holdings.

86 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • UBS AM held 108 shares of Avalyn Pharma worth $3.08K as of Q3 2026.
  • Avalyn Pharma was a new UBS AM position in Q3 2026.
  • Avalyn Pharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3983 holding.
  • 86 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.